日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

复发性多发性骨髓瘤的挽救性自体移植:GMMG ReLApsE III期试验的长期随访

Baertsch, Marc-Andrea; Schlenzka, Jana; Hielscher, Thomas; Raab, Marc S; Sauer, Sandra; Merz, Maximilian; Mai, Elias Karl; Müller-Tidow, Carsten; Luntz, Steffen; Jauch, Anna; Brossart, Peter; Goerner, Martin; Klein, Stefan; Glass, Bertram; Reimer, Peter; Graeven, Ullrich; Fenk, Roland; Haenel, Mathias; von Metzler, Ivana; Lindemann, Hans W; Scheid, Christof; Blau, Igor-Wolfgang; Salwender, Hans J; Noppeney, Richard; Besemer, Britta; Weisel, Katja C; Goldschmidt, Hartmut

Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial

帕尼单抗联合 5-氟尿嘧啶和亚叶酸钙或单独使用 5-氟尿嘧啶和亚叶酸钙作为 RAS 野生型转移性结直肠癌的维持治疗(PanaMa,AIO KRK 0212):一项随机、开放标签、II 期试验的最终疗效分析

Stahler, Arndt; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; Fischer von Weikersthal, Ludwig; Caca, Karel; Goekkurt, Eray; Ballhausen, Alexej; Sommerhäuser, Greta; Alig, Annabel H S; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P

Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance

德国淋巴瘤联盟开展的一项II期研究结果显示,伊布替尼联合奥妥珠单抗治疗未经化疗的晚期滤泡性淋巴瘤疗效显著。

Schmidt, Christian; Scheubeck, Gabriel; Jurinovic, Vindi; Sökler, Martin; Forstpointner, Roswitha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Graeven, Ullrich; Marks, Reinhard; Hänel, Mathias; Liersch, Rüdiger; Dürig, Jan; Pott, Christiane; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang

Erratum to: "Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance"

更正:“伊布替尼和奥妥珠单抗联合治疗未经治疗的晚期滤泡性淋巴瘤:德国淋巴瘤联盟 II 期研究的结果”

Schmidt, Christian; Scheubeck, Gabriel; Jurinovic, Vindi; Sökler, Martin; Forstpointner, Roswitha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Graeven, Ullrich; Marks, Reinhard; Hänel, Mathias; Liersch, Rüdiger; Dürig, Jan; Pott, Christiane; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang

Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple myeloma

基于基线MRI预测多发性骨髓瘤治疗反应和微小残留病灶的自动化放射组学模型

Bauer, Fabian; Hajiyianni, Marina; Weinhold, Niels; Grözinger, Martin; Kächele, Jessica; Menis, Ekaterina; Raab, Marc-Steffen; Sauer, Sandra; Jauch, Anna; Weber, Tim F; Debic, Manuel; Besemer, Britta; Horger, Marius; Afat, Saif; Hoffmann, Martin; Hoffend, Johannes; Kraemer, Doris; Graeven, Ullrich; Ringelstein, Adrian; Dürig, Jan; Umutlu, Lale; Schlemmer, Heinz-Peter; Goldschmidt, Hartmut; Maier-Hein, Klaus; Delorme, Stefan; Mai, Elias K; Wennmann, Markus; Neher, Peter

Patient Characteristics and Different Decision Paths for Establishing Palliative Care for Patients Admitted via the Emergency Department

患者特征及通过急诊科入院患者建立姑息治疗的不同决策路径

Munsch, Christiane; Bergrath, Sebastian; Kreß, Jessika Stefanie; Graeven, Ullrich; Rödler, Jana Vienna

Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial

GMMG-CONCEPT试验中用于新诊断高危多发性骨髓瘤风险分层的心脏生物标志物

Leypoldt, Lisa B; Guo, Linlin; Besemer, Britta; Hänel, Mathias; Raab, Marc-S; Mann, Christoph; Michel, Christian S; Reinhardt, Hans Christian; Blau, Igor Wolfgang; Görner, Martin; Ko, Yon-Dschun; de Wit, Maike; Salwender, Hans; Scheid, Christof; Graeven, Ullrich; Peceny, Rudolf; Staib, Peter; Dieing, Annette; Goldschmidt, Hartmut; Bokemeyer, Carsten; Zeller, Tanja; Westermann, Dirk; Weisel, Katja C; Twerenbold, Raphael; Beitzen-Heineke, Antonia

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

伊沙妥昔单抗、卡非佐米、来那度胺和地塞米松联合治疗高危新诊断多发性骨髓瘤

Leypoldt, Lisa B; Tichy, Diana; Besemer, Britta; Hänel, Mathias; Raab, Marc S; Mann, Christoph; Munder, Markus; Reinhardt, Hans Christian; Nogai, Axel; Görner, Martin; Ko, Yon-Dschun; de Wit, Maike; Salwender, Hans; Scheid, Christof; Graeven, Ullrich; Peceny, Rudolf; Staib, Peter; Dieing, Annette; Einsele, Hermann; Jauch, Anna; Hundemer, Michael; Zago, Manola; Požek, Ema; Benner, Axel; Bokemeyer, Carsten; Goldschmidt, Hartmut; Weisel, Katja C

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients

新诊断多发性骨髓瘤早期发病率和死亡率的预测因素:来自 3700 例患者的 5 项随机、对照、III 期试验的数据

Mai, Elias K; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans J; Zweegman, Sonja; Raab, Marc S; Munder, Markus; Pantani, Lucia; Mancuso, Katia; Brossart, Peter; Beksac, Meral; Blau, Igor W; Dürig, Jan; Besemer, Britta; Fenk, Roland; Reimer, Peter; van der Holt, Bronno; Hänel, Mathias; von Metzler, Ivana; Graeven, Ullrich; Müller-Tidow, Carsten; Boccadoro, Mario; Scheid, Christof; Dimopoulos, Meletios A; Hillengass, Jens; Weisel, Katja C; Cavo, Michele; Sonneveld, Pieter; Goldschmidt, Hartmut

The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network

在复发或难治性套细胞淋巴瘤中,利妥昔单抗、大剂量阿糖胞苷和地塞米松联合硼替佐米治疗——欧洲套细胞淋巴瘤网络的一项随机、开放标签III期试验

Fischer, Luca; Jiang, Linmiao; Dürig, Jan; Schmidt, Christian; Stilgenbauer, Stephan; Bouabdallah, Krimo; Solal-Celigny, Philippe; Scholz, Christian W; Feugier, Pierre; de Wit, Maike; Trappe, Ralf Ulrich; Hallek, Michael; Graeven, Ullrich; Hänel, Mathias; Hoffmann, Martin; Delwail, Vincent; Macro, Margaret; Greiner, Jochen; Giagounidis, Aristoteles A N; Dargel, Beate; Durot, Eric; Foussard, Charles; Silkenstedt, Elisabeth; Weigert, Oliver; Pott, Christiane; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva; Ribrag, Vincent; Dreyling, Martin